Evidence map›Paper›PMID 35844826›Full record

ArticleHealth science reports2022

Large-scale screening for factor V Leiden (G1691A), prothrombin (G20210A), and MTHFR (C677T) mutations in Greek population.

Alkistis Raptopoulou, Vassiliki Michou, Niki Mourtzi, Efstathia G Papageorgiou, Chrysa Voyiatzaki, Vassilis Tsilivakos, Apostolos Beloukas, Thaleia A Bei

Open access · goldAbstract read
In one paragraph

Article in Health science reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Observational
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Alkistis RaptopoulouDepartment of Biomedical Science University of West Attica Aigaleo Greece.
Vassiliki MichouLaboratory of Cellular Biology and Immunology Locus Medicus S.A Athens Greece.
Niki MourtziDivision of Endocrinology, Metabolism and Diabetes, First Department of Pediatrics National and Kapodistrian University of Athens Medical School, "Aghia Sophia" Children's Hospital Athens Greece.
Efstathia G PapageorgiouDepartment of Biomedical Science University of West Attica Aigaleo Greece.
Chrysa VoyiatzakiDepartment of Biomedical Science University of West Attica Aigaleo Greece.
Vassilis TsilivakosLaboratory of Cellular Biology and Immunology Locus Medicus S.A Athens Greece.
Apostolos BeloukasDepartment of Biomedical Science University of West Attica Aigaleo Greece.
Thaleia A BeiDepartment of Biomedical Science University of West Attica Aigaleo Greece.ORCID https://orcid.org/0000-0003-4663-3260
University of West Attica · GRAthens Medical Center · GRNational and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and aims: To provide a fair estimate of the prevalence of factor V Leiden (FVL) (G1691A), prothrombin (G20210A), and MTHFR (C677T) mutations in the Greek population. Methods: We genotyped a representative sample of 974 apparently healthy Greek adults by the method of real-time PCR and we calculated the allele frequencies of factor V Leiden (FVL) (G1691A), prothrombin (G20210A), and MTHFR (C677T) mutations. In addition, we determined the frequency of co-occurrence of FVL (1691A) and prothrombin (20210A), FVL (1691A) and MTHFR (677T), prothrombin (20210A) and MTHFR (677T) mutations. Results: Τhe career frequencies of FVL (1691A), prothrombin (20210A), and MTHFR (677T) alleles were 7.5%, 4.5%, and 49.3% while the allele frequencies were 4%, 2.25%, and 39.5%, respectively. The coexistence of the allele frequencies combinations of two, FVL (1691A) and Prothrombin (20210A), FVL (1691A) and MTHFR (677T), prothrombin (20210A) and MTHFR (677T) was found in 1 (0.9%), 29 (3.5%), and 22 (3%) samples, respectively. Triple heterozygous carriers were not found. Conclusion: Allele frequencies of the two (FVL and MTHFR) mutations are higher compared with published data. The large sample size of our study enhances the validity of our results and suggests a biological affinity of Greek population with Southern Italian populations.

Indexed as

FVLGreeceMTHFRprothrombinthrombophilia

Identifiers

PMID35844826
PMCPMC9284178
OpenAlexW4285605237

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.